A carregar...
Development and Characterization of a Differentiated Thyroid Cancer Cell Line Resistant to VEGFR-Targeted Kinase Inhibitors
BACKGROUND: Vascular endothelial growth factor-targeted kinase inhibitors have emerged as highly promising therapies for radioiodine-refractory metastatic differentiated thyroid cancer. Unfortunately, drug resistance uniformly develops, limiting their therapeutic efficacies and thereby constituting...
Na minha lista:
| Publicado no: | J Clin Endocrinol Metab |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5393484/ https://ncbi.nlm.nih.gov/pubmed/24628546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-2658 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|